A Phase II-R and a Phase III Trial Evaluating Both *Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Cancer - Pancreatic
Seth Kaufman, MD
D’Amour Center for Cancer Care
3350 Main Street, Springfield MA 01199
The purpose of this study is to evaluate the effects (good and bad) of the use of radiation after completion of gemcitabine.
T1-T3 pancreatic cancer; must have completed surgery
Rae Lynn Defeo